Quick Answer
Roivant Sciences Ltd. reported Total Revenue of $29.05 million for fiscal year 2025.
Roivant Sciences Ltd. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $29.05M | -11.2% |
| 2024 | $32.71M | +3.8% |
| 2023 | $31.53M | -43.0% |
| 2022 | $55.29M | +132.3% |
| 2021 | $23.80M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $2.00M | -77.8% | +27.2% |
| September 30, 2025 | $1.57M | -64.9% | -27.6% |
| June 30, 2025 | $2.17M | -72.8% | -75.9% |
| December 31, 2024 | $9.02M | -42.1% | +101.5% |
| September 30, 2024 | $4.47M | +22.7% | -44.0% |
| June 30, 2024 | $7.99M | -63.1% | -48.7% |
| December 31, 2023 | $15.56M | -8.7% | +326.6% |
| September 30, 2023 | $3.65M | -70.9% | -83.1% |
- Roivant Sciences Ltd. showed a decrease of -11.2% in Total Revenue compared to the prior fiscal year.
- Over the 2021–2025 period, Roivant Sciences Ltd.’s total revenue has grown by 22.1% (from $23.80 million to $29.05 million).
- The most recent figure is from Roivant Sciences Ltd.’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 29, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: